of the deaths attributed to malformation and infection in Tables 2 and 3 .
Discussion
The concept of a sudden infant death syndrome arose when, after reductions in deaths from infectious disease, it was found that a sizeable proportion of infant deaths occurred in children who had seemed to be completely well and in whom no consequential pathological features could be found.6
These sudden deaths are dealt with by the coroner and forensic pathologists who are concerned primarily with the identification of unnatural deaths.
Having excluded unnatural causes, the problem of labelling these deaths remained. Emery argues that sudden infant death syndrome, cot death, crib death, and other synonyms were invented for the convenience of considering these deaths as a single entity. 7 The possibility of a multiple aetiology for sudden infant deaths has been known to forensic pathologists for many years.8 9
The description and publicity of the sudden infant death syndrome in the early 1960s was followed by a rapid increase in the number of these deaths registered around the world.6 Some of this increase was probably correction of the registration of deaths which, because of the previous lack of a suitable diagnostic label, had been recorded as respiratory or gastrointestinal infections. Doubts have been expressed, however, about the quality of paediatric certification and the continuing increase in registrations of sudden infant death syndrome deaths.2 Seventy six of the 128 sudden deaths caused by malformation in this series were from conditions not usually considered as life threatening congenital defects (Table 2 ), but they could not be considered as inexplicable deaths: nor could the 157 sudden deaths from infection (Table 3) be classified as inexplicable. Thus by the definition of Stanton and Oakley,3 among the 837 sudden postneonatal deaths in this series, 739 would be cot deaths of which only 62% were histologically unexplained.
Fear of cot death haunts many young parents. Inflated numbers of cot deaths do not ease their anxiety. Misdiagnosis also hinders attempts to understand aetiological mechanisms. Published reports on the sudden infant death syndrome are confused by variations in definition. Meningococcaemia and leukaemia may both present with purpura but this does not mean that they share a common aetiology, and considering them as the same can only confuse.
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Successful treatment of fetal atrial flutter and congestive heart failure K HIRATA, H KATO, F YOSHIOKA, AND T MATSUNAGA Departments of Pediatrics and Obstetrics, Kurume University School of Medicine, Japan SUMMARY Fetal supraventricular tachycardia may cause congestive heart failure, hydrops fetalis, and intrauterine death. Tachycardia in a fetus of 34 weeks' gestation was diagnosed as atrial flutter by echocardiography, and was successfully treated by giving the mother digoxin.
Since visualisation of the fetal heart by echocardiography has become available, prenatal diagnosis of congenital cardiac anomalies and fetal arrhythmia has been possible.'-3 We have evaluated the structure of the fetal heart and the great vessels by two dimensional echocardiography, and diagnosed arrhythmia by simultaneously recording the motion of the atrial wall and the ventricular wall of the fetal heart by M mode echocardiography. Certain fetal arrhythmias such as supraventricular tachycardia or A-V block have clinical importance, since they may be the cause of congestive heart failure and evaluation and treatment of these conditions are, therefore, necessary.
Case report
The mother, a 28 year old gravida 1, para 0, had an uneventful pregnancy until week 34 of gestation when she complained of abdominal pain and was referred to Kurume University Hospital. Fetal echocardiography was carried out and showed an atrial rate of 460 beats/minute and a ventricular rate of 230 beats/minute, without any structural anomalies of the heart (Fig. 1) . Atrial flutter was diagnosed. Digoxin (0-5 mg) was given to the mother and further doses of 0-5 mg and 0-25 mg were administered three and 12 hours later. The fetal heart rate was continuously monitored during this time and repeated electrocardiograms were made. Five hours after the third dose of digoxin, the fetal heart rate dropped from 230 to 135 beats/minute: at that time the digoxin concentration in maternal venous blood was 1-4 ng/ml. The mother was treated by a daily oral dose of 0-25 mg of digoxin and showed no signs of digoxin intoxication. Echocardiography, undertaken when the fetal heart rate had returned to normal showed massive pleural
